Pozniak, A L <br/><br/>
Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?  [electronic resource] 

 -  HIV medicine  2000 
 - 7-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1464-2662 
<br/><br/><label>Standard No.: </label>10.1046/j.1468-1293.2000.00006.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--therapeutic use<br/>Drug Therapy, Combination<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Protease Inhibitors--adverse effects<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Treatment Outcome